Richard Anderson
Stock Analyst at Wedbush
(4.26)
# 363
Out of 4,762 analysts
134
Total ratings
71.01%
Success rate
7.5%
Average return
Main Sectors:
Stocks Rated by Richard Anderson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| STRW Strawberry Fields REIT | Maintains: Outperform | $12 → $14 | $12.46 | +12.36% | 2 | Mar 5, 2025 | |
| VTR Ventas | Maintains: Outperform | $69 → $78 | $66.35 | +17.56% | 7 | Feb 14, 2025 | |
| DOC Healthpeak Properties | Maintains: Outperform | $24 → $27 | $20.20 | +33.66% | 3 | Feb 14, 2025 | |
| WELL Welltower | Upgrades: Outperform | $145 → $167 | $147.38 | +13.31% | 5 | Feb 14, 2025 | |
| SAFE Safehold | Reiterates: Neutral | $20 → $19 | $18.83 | +0.90% | 4 | Feb 7, 2025 | |
| UMH UMH Properties | Reiterates: Neutral | $20 | $17.89 | +11.79% | 4 | Jan 13, 2025 | |
| DEI Douglas Emmett | Upgrades: Outperform | $19 → $21 | $16.06 | +30.76% | 2 | Jan 2, 2025 | |
| HR Healthcare Realty Trust | Downgrades: Underperform | $18 → $16 | $16.32 | -1.96% | 8 | Jan 2, 2025 | |
| CTRE CareTrust REIT | Downgrades: Underperform | $34 → $26 | $27.01 | -3.74% | 2 | Jan 2, 2025 | |
| BXP BXP, Inc. | Downgrades: Underperform | $81 → $70 | $66.09 | +5.92% | 5 | Jan 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $34 → $33 | $32.09 | +2.84% | 3 | Jan 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $72 | $63.54 | +13.31% | 1 | Dec 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $120 → $110 | $98.52 | +11.65% | 7 | Dec 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $209 | $181.05 | +15.44% | 5 | Oct 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $40 | $35.27 | +13.41% | 3 | Sep 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $118 → $131 | $118.40 | +10.64% | 4 | Aug 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $68 → $75 | $68.97 | +8.74% | 5 | Aug 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $264 → $301 | $292.88 | +2.77% | 8 | Aug 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $45 → $49 | $42.97 | +14.03% | 4 | Aug 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $44 → $45 | $36.16 | +24.45% | 3 | Aug 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $28 → $33 | $26.92 | +22.59% | 3 | Aug 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $154 → $184 | $161.77 | +13.74% | 4 | Aug 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $22 | $15.11 | +45.60% | 2 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $17 | $11.53 | +47.44% | 3 | May 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $51 | $49.75 | +2.51% | 2 | May 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $59 → $49 | $56.09 | -12.64% | 5 | Apr 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $45 | $39.15 | +14.94% | 1 | Apr 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $67 | $66.85 | +0.22% | 2 | Mar 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $64 → $66 | $72.87 | -9.43% | 3 | Mar 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $11 → $7.5 | $2.72 | +175.74% | 5 | Feb 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $94 | $96.87 | -2.96% | 1 | Oct 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $14 | $11.12 | +25.90% | 2 | Oct 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $16 | $16.59 | -3.56% | 5 | Oct 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $34 | $36.58 | -7.05% | 1 | Oct 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $179 | $210.04 | -14.78% | 1 | Oct 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | n/a | $4.04 | - | 2 | May 7, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | n/a | $8.91 | - | 5 | Nov 6, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $4.54 | - | 2 | Jul 10, 2017 |
Strawberry Fields REIT
Mar 5, 2025
Maintains: Outperform
Price Target: $12 → $14
Current: $12.46
Upside: +12.36%
Ventas
Feb 14, 2025
Maintains: Outperform
Price Target: $69 → $78
Current: $66.35
Upside: +17.56%
Healthpeak Properties
Feb 14, 2025
Maintains: Outperform
Price Target: $24 → $27
Current: $20.20
Upside: +33.66%
Welltower
Feb 14, 2025
Upgrades: Outperform
Price Target: $145 → $167
Current: $147.38
Upside: +13.31%
Safehold
Feb 7, 2025
Reiterates: Neutral
Price Target: $20 → $19
Current: $18.83
Upside: +0.90%
UMH Properties
Jan 13, 2025
Reiterates: Neutral
Price Target: $20
Current: $17.89
Upside: +11.79%
Douglas Emmett
Jan 2, 2025
Upgrades: Outperform
Price Target: $19 → $21
Current: $16.06
Upside: +30.76%
Healthcare Realty Trust
Jan 2, 2025
Downgrades: Underperform
Price Target: $18 → $16
Current: $16.32
Upside: -1.96%
CareTrust REIT
Jan 2, 2025
Downgrades: Underperform
Price Target: $34 → $26
Current: $27.01
Upside: -3.74%
BXP, Inc.
Jan 2, 2025
Downgrades: Underperform
Price Target: $81 → $70
Current: $66.09
Upside: +5.92%
Jan 2, 2025
Upgrades: Outperform
Price Target: $34 → $33
Current: $32.09
Upside: +2.84%
Dec 17, 2024
Initiates: Neutral
Price Target: $72
Current: $63.54
Upside: +13.31%
Dec 6, 2024
Maintains: Neutral
Price Target: $120 → $110
Current: $98.52
Upside: +11.65%
Oct 25, 2024
Reiterates: Outperform
Price Target: $209
Current: $181.05
Upside: +15.44%
Sep 20, 2024
Reiterates: Outperform
Price Target: $40
Current: $35.27
Upside: +13.41%
Aug 5, 2024
Maintains: Outperform
Price Target: $118 → $131
Current: $118.40
Upside: +10.64%
Aug 5, 2024
Maintains: Neutral
Price Target: $68 → $75
Current: $68.97
Upside: +8.74%
Aug 5, 2024
Maintains: Neutral
Price Target: $264 → $301
Current: $292.88
Upside: +2.77%
Aug 5, 2024
Maintains: Outperform
Price Target: $45 → $49
Current: $42.97
Upside: +14.03%
Aug 5, 2024
Maintains: Outperform
Price Target: $44 → $45
Current: $36.16
Upside: +24.45%
Aug 5, 2024
Maintains: Outperform
Price Target: $28 → $33
Current: $26.92
Upside: +22.59%
Aug 5, 2024
Maintains: Outperform
Price Target: $154 → $184
Current: $161.77
Upside: +13.74%
May 30, 2024
Reiterates: Outperform
Price Target: $22
Current: $15.11
Upside: +45.60%
May 28, 2024
Reiterates: Neutral
Price Target: $17
Current: $11.53
Upside: +47.44%
May 17, 2024
Reiterates: Outperform
Price Target: $51
Current: $49.75
Upside: +2.51%
Apr 25, 2024
Downgrades: Neutral
Price Target: $59 → $49
Current: $56.09
Upside: -12.64%
Apr 22, 2024
Initiates: Neutral
Price Target: $45
Current: $39.15
Upside: +14.94%
Mar 28, 2024
Reiterates: Neutral
Price Target: $67
Current: $66.85
Upside: +0.22%
Mar 18, 2024
Maintains: Outperform
Price Target: $64 → $66
Current: $72.87
Upside: -9.43%
Feb 20, 2024
Downgrades: Neutral
Price Target: $11 → $7.5
Current: $2.72
Upside: +175.74%
Oct 3, 2023
Initiates: Outperform
Price Target: $94
Current: $96.87
Upside: -2.96%
Oct 3, 2023
Initiates: Neutral
Price Target: $14
Current: $11.12
Upside: +25.90%
Oct 3, 2023
Initiates: Outperform
Price Target: $16
Current: $16.59
Upside: -3.56%
Oct 3, 2023
Initiates: Neutral
Price Target: $34
Current: $36.58
Upside: -7.05%
Oct 3, 2023
Initiates: Neutral
Price Target: $179
Current: $210.04
Upside: -14.78%
May 7, 2018
Upgrades: Neutral
Price Target: n/a
Current: $4.04
Upside: -
Nov 6, 2017
Upgrades: Neutral
Price Target: n/a
Current: $8.91
Upside: -
Jul 10, 2017
Upgrades: Buy
Price Target: n/a
Current: $4.54
Upside: -